CD14 and melanoma: The percentage of CD14+ cells isolated from apheresis products, purity of isolated CD14+ cells, efficiency of CD14+ cell selection as well as viability and yield of IDCs were indistinguishable between melanoma patients and normal volunteer blood donors used as control [23].